propentofylline has been researched along with Schizophrenia in 1 studies
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propentofylline is a novel xantine derivative which is being developed for treatment of degenerative and vascular dementia." | 6.73 | A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia. ( Abbasi, SH; Ahmadi-Abhari, SA; Akhondzadeh, S; Derakhshan, MK; Fotouhi, A; Ghoreishi, A; Hajiazim, M; Khodaie-Ardakani, MR; Mohammadi, MR; Noorbala, AA; Salimi, S, 2008) |
| "Propentofylline is a novel xantine derivative which is being developed for treatment of degenerative and vascular dementia." | 2.73 | A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia. ( Abbasi, SH; Ahmadi-Abhari, SA; Akhondzadeh, S; Derakhshan, MK; Fotouhi, A; Ghoreishi, A; Hajiazim, M; Khodaie-Ardakani, MR; Mohammadi, MR; Noorbala, AA; Salimi, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salimi, S | 1 |
| Fotouhi, A | 1 |
| Ghoreishi, A | 1 |
| Derakhshan, MK | 1 |
| Khodaie-Ardakani, MR | 1 |
| Mohammadi, MR | 1 |
| Noorbala, AA | 1 |
| Ahmadi-Abhari, SA | 1 |
| Hajiazim, M | 1 |
| Abbasi, SH | 1 |
| Akhondzadeh, S | 1 |
1 trial available for propentofylline and Schizophrenia
| Article | Year |
|---|---|
A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female | 2008 |